Results 161 to 170 of about 38,283 (218)

Clinical and genomic characterization of Influenza A co-infection with SARS-CoV-2 and Influenza B: a respiratory surveillance study in Assam, India. [PDF]

Sci Rep
Sarmah N, Siddique AI, Dutta M, Jakharia A, Bali N, Vijay N, Gupta N, Kanungo S, Borkakoty B.   +8 more
europepmc   +1 more source

Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergence. [PDF]

EBioMedicine
Harvey R, Welsh C, Byrne AM, Greenwood D, Stevenson-Leggett P, Galiano M, Bailey D, Chan YW, Boateng J, Wolmuth-Gordon H, Whitaker H, Brown KE, Jeffery-Smith A, Allen A, Amirthanlingam G, Fossum E, Vikse EL, Rohringer A, Hungnes O, Bragstad K, Swanton C, Williams B, Gandhi S, Gamblin S, Carr EJ, Lewis NS, Wall EC, Wu MY, Crick Serology Pipeline, Legacy Investigators.   +29 more
europepmc   +1 more source

Rab11Bis required for binding and entry of recent H3N2, but not H1N1, influenza A isolates. [PDF]

J Virol
Turner AH, Jaffrani SA, Kubinski HC, Ajayi DP, Owens MB, Fanuele CD, McTigue MP, Appenzeller CL, Bowling A, Despres HW, Schmidt MM, Shirley DJ, Crothers JW, Barrantes-Reynolds R, Bruce EA.   +14 more
europepmc   +1 more source

Human-Origin Influenza A(H3N2) Viruses Revealed in Swine Farms During the Period 2022-2025 in Kazakhstan. [PDF]

Animals (Basel)
Klivleyeva N, Glebova T, Saktaganov N, Baimukhametova A, Kalkozhayeva M, Ongarbayeva N, Ibragimova I, Ibragimov P, Webby R.   +8 more
europepmc   +1 more source

Antigenic mapping of H2 influenza viruses recognized by ferret and human sera and predicting antigenically significant sites. [PDF]

mSphere
Reneer ZB, Ngyen C, Corn MR, Paugh JL, Reynolds OC, O'Hara E, Ross TM, Baric RS.   +7 more
europepmc   +1 more source

Influenza vaccine effectiveness against outpatient acute respiratory illness with laboratory-confirmed influenza, United States, 2024-25 season. [PDF]

Clin Infect Dis
Chung JR, Price AM, House SL, Mills J, Wernli KJ, Sanchez M, Martin ET, Vaughn IA, Murugan V, Kramer J, Saade EA, Faryar K, Gaglani M, Raiyani C, Zimmerman RK, Taylor LH, Williams OL, Walter EB, DaSilva J, Kirby MK, Levine MZ, Kondor R, Noble EK, Sumner KM, Ellington SR, Flannery B, US Flu VE Network Investigators.   +26 more
europepmc   +1 more source

Cross-reactive antibody and T-cell responses after influenza virus infection in community-dwelling older adults. [PDF]

J Virol
van Pul L, Rosendahl Huber SK, Jacobi R, Hendriks M, van Schuijlenburg R, van Sleen Y, Bijvank E, de Wit J, van Beek J.   +8 more
europepmc   +1 more source

Development of a Trivalent Seasonal Influenza Vaccine Using Long α-Helix-Mediated Trimeric HA1 Proteins Produced in Baculovirus-Insect Cell System. [PDF]

MedComm (2020)
Guo N, Xu Z, Chen X, Han X, Xue T, Yan J, Huang Q.   +6 more
europepmc   +1 more source

The Dual Role of Preexisting Immunity in Influenza: Protective Recall Versus Constraint of Novel Responses. [PDF]

Immunol Rev
Fox A, Zhu Z, Sánchez-Ovando S.
europepmc   +1 more source

Development of a nano-emulsion and evaluation of its intradermal adjuvant function of Swine Influenza H3N2 Vaccine. [PDF]

Virol J
Ruan Z, Deng B, Yin W, Ma F, Lu Y, Wang H.   +5 more
europepmc   +1 more source